A critical breakthrough in cancer investigation is emerging with the use of VHH fragments to re-engage dysfunctional p53. This vital tumor inhibitor protein is frequently lost in many types of tumors, leading https://bookmarkinglog.com/story21983583/mini-antibodies-revive-p53-a-new-pathway-for-malignant-treatment